Efficacy and safety of amisulpride treatment in schizophrenia: Comparison with haloperidol
Objective: Amisulpride is a novel atypical antipsychotic with preferential affinity for presynaptic dopaminergic D2 and D3 receptors. There have been no clinical studies conducted with amisulpride in schizophrenia in Turkey. The aim of this open-label study was to compare the efficacy and safety of...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mesut Çetin
2021-03-01
|
| Edice: | Psychiatry and Clinical Psychopharmacology |
| Témata: | |
| On-line přístup: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/370 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|